ANMED HEALTH
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.3M
- Transactions
- 1,494
- Companies
- 40
- Average per transaction
- $1,529
Who reported the payments
| Insmed, Inc. | $578,112 |
| Medtronic | $349,417 |
| Abbott | $304,214 |
| United Therapeutics Corporation | $208,024 |
| Janssen Research & Development, LLC | $126,812 |
| CSL Behring | $103,777 |
| Novo Nordisk AS | $73,751 |
| Biotronik Inc. | $72,519 |
| E.r. Squibb & Sons, L.L.C. | $68,306 |
| Merck | $43,751 |
| Esperion Therapeutics, Inc. | $31,702 |
| Biosense Webster, Inc. | $30,200 |
| Boston Scientific | $28,624 |
| Gyrus ACMI, Inc. | $25,162 |
| Medartis Inc. | $23,493 |
| Barco, Inc. | $23,400 |
| Novartis | $18,093 |
| Actelion Pharmaceuticals, Ltd | $16,830 |
| AstraZeneca | $14,666 |
| Eyetech Digital Systems, Inc. | $14,500 |
| Stryker | $14,003 |
| Sanofi US Services Inc. | $13,229 |
| Lexicon Pharmaceuticals, Inc. | $11,441 |
| Actelion Pharmaceuticals US, Inc. | $8,998 |
| GE HealthCare | $8,710 |
| CMS Imaging, Inc. | $8,530 |
| Boehringer Ingelheim | $8,438 |
| Genentech, Inc. | $8,000 |
| Mannkind Corporation | $7,000 |
| Spectrum Pharmaceuticals Inc. | $6,800 |
| Astrazeneca UK Limited | $5,857 |
| Amgen | $5,631 |
| Pfizer | $4,900 |
| Edwards Lifesciences | $4,000 |
| Medline Industries LP | $3,625 |
| KARL Storz Endoscopy-america | $2,107 |
| Aesculap, Inc. | $2,082 |
| Johnson & Johnson | $1,282 |
| Hill-rom Company, Inc | $1,225 |
| Smith+Nephew | $1,006 |